ASSESSMENT CLINICAL FEATURES AND TREATMENT OUTCOME OF OVARIAN SEX CORD-STROMAL TUMORS AT VIETNAM NATIONAL CANCER HOSPITAL

Nguyễn Thị Lý Linh1,, Lê Thanh Đức2, Nguyễn Mạnh Tuấn3
1 Hanoi Medical University
2 K Hospital
3 National Hospital for Tropical Diseases

Main Article Content

Abstract

Purpose: We aimed to assess the clinical features, treatment strategy and outcome of ovarian sex cord-stromal tumors (SCSTs). Materials and Methods: Medical records of 72 casesdiagnosed SCSTs on from 2016 through 2020 in Vietnam National Cancer Hospital were reviewed retrospectively. Results: patients with mean age of 51.6±15.7were reviewed. The most common subtypes were granulosa cell tumors (GCTs) and thecoma-fibroma groups. The mean diameter of the tumor was 11.6 cm (range: 3.5-25cm). The majority of ovarian GCTs were diagnosed at anearly stage (69.2%) and 19.2% and 11.5% for stage II and III, respectively. For a median follow up of 37.0 months (range 8.6-69.6 months), the 5-year overall-survival (OS) and disease-free-survival (DFS) rates were 83.3% and 67.7% respectively. Advanced stage and residual tumor werepoor prognosis factors in patient with ovarian GCTs (p<0.05). Conclusion: SCSTs are uncommon ovarian tumors with a wide age range and diverse histological types. The majority malignant subtypesare GCTs which are diagnosed at an early age and have favorable prognosis. Initial stageand residual diseaseare important prognostic factors of this type.

Article Details

References

1. Chi, Dennis S;Berchuck, Andrew; Dizon, Don S; Yashar, Catheryn M. Principle and practice of gynecologic oncology. Seventh ed; Wolters Kluwer; 2017; 1438-1486.
2. Cho YJ, Lee HS, Kim JM, Joo KY, Kim ML. Clinical characteristics and surgical management options for ovarian fibroma/fibrothecoma: a study of 97 cases. Gynecol Obstet Invest. 2013; 76(3):182–187.
3. Chan JK, Zhang M, Kaleb C, và CS. Prognostic factors responsible for survival in sex cord stromal tumors of the ovary—A multivariate analysis. Gynecol Oncol. 2005 Jan;96(1):204-9.doi: 10.1016/j.ygyno.2004.09.019.
4. Homesley HD, Bundy BN, Hurteau JA, và CS. Bleomycin, etoposide, and cisplatin combination therapy of ovarian granulosa cell tumors and other stromal malignancies: a Gynecologic Oncology Group study. Gynecol Oncol. 1999;72(2):131-137.
5. Mangili G, Sigismondi C, Frigerio L, và CS. Recurrent granulosa celltumors (GCTs) of the ovary: a MITO-9 retrospective study. GynecolOncol 2013;130:38–42.
6. NCCN Clinical Practice Guidelines in Oncology: Ovarian Cancer Including Fallopian Tube Cancer and Primary Peritoneal Cancer, Version 1.2020.
7. Schultz KAP, Harris AK, Schneider DT, và CS. Ovarian sex cord-stromaltumors. J Oncol Pract. 2016;12:940–6.
8. Stenwig JT, Hazekamp JT, Beecham JB.Granulosa cell tumors of theovary. A clinicopathological study of 118 cases with long-term followup.Gynecol Oncol.1979;7(2):136 – 52.
9. Van Meurs HS, Buist MR, Westermann AM, và CS. Effectiveness of chemotherapy in measurable granulosa cell tumors.Int J Gynecol Cancer. 2014;24(3):496-505.